23,394 Shares in Teleflex Incorporated (NYSE:TFX) Purchased by Trexquant Investment LP

Trexquant Investment LP purchased a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 23,394 shares of the medical technology company's stock, valued at approximately $4,164,000. Trexquant Investment LP owned approximately 0.05% of Teleflex at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Headlands Technologies LLC acquired a new stake in shares of Teleflex in the 4th quarter worth $29,000. Geode Capital Management LLC raised its stake in Teleflex by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company's stock worth $202,161,000 after purchasing an additional 8,307 shares during the period. Rodgers Brothers Inc. boosted its holdings in Teleflex by 12.7% in the 4th quarter. Rodgers Brothers Inc. now owns 3,740 shares of the medical technology company's stock valued at $666,000 after purchasing an additional 420 shares during the last quarter. Meeder Asset Management Inc. purchased a new stake in shares of Teleflex in the 4th quarter valued at approximately $1,094,000. Finally, Wellington Management Group LLP increased its holdings in shares of Teleflex by 42.0% during the 4th quarter. Wellington Management Group LLP now owns 223,438 shares of the medical technology company's stock worth $39,767,000 after buying an additional 66,075 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Stock Down 6.1 %

NYSE:TFX traded down $8.24 during mid-day trading on Thursday, hitting $126.93. The stock had a trading volume of 168,728 shares, compared to its average volume of 607,316. Teleflex Incorporated has a twelve month low of $124.66 and a twelve month high of $249.91. The stock has a 50-day simple moving average of $149.82 and a two-hundred day simple moving average of $183.14. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $5.89 billion, a PE ratio of 25.27, a PEG ratio of 1.73 and a beta of 1.19.

Remove Ads

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts' consensus estimates of $3.86 by $0.03. The business had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. On average, equities research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.07%. Teleflex's payout ratio is currently 95.77%.

Wall Street Analysts Forecast Growth

TFX has been the subject of several analyst reports. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. Piper Sandler restated a "neutral" rating and issued a $140.00 price objective (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Truist Financial lowered their target price on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating for the company in a research note on Monday, March 3rd. Morgan Stanley reduced their price target on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 5th. Finally, Raymond James downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Teleflex presently has an average rating of "Hold" and a consensus target price of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.